{"title":"Pharmacogenomic-guided treatment slightly improves antidepressant efficacy","authors":"","doi":"10.1002/pu.31165","DOIUrl":null,"url":null,"abstract":"<p>A systematic review and meta-analysis encompassing 15 clinical trials has concluded that pharmacogenomic-guided depression treatment results in a small improvement in antidepressant efficacy relative to treatment as usual. There was no difference in treatment discontinuation rates between pharmacogenomic-guided and conventional treatment.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 6","pages":"3"},"PeriodicalIF":0.0000,"publicationDate":"2024-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31165","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
A systematic review and meta-analysis encompassing 15 clinical trials has concluded that pharmacogenomic-guided depression treatment results in a small improvement in antidepressant efficacy relative to treatment as usual. There was no difference in treatment discontinuation rates between pharmacogenomic-guided and conventional treatment.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
